Analogic has a new leader, and it’s a familiar name to medical imaging industry veterans. Longtime Siemens employee Thomas Miller will be joining the Peabody, MA-based firm as president and CEO in October. Miller has most recently served as
Analogic has a new leader, and its a familiar name to medical imaging industry veterans. Longtime Siemens employee Thomas Miller will be joining the Peabody, MA-based firm as president and CEO in October. Miller has most recently served as president and CEO at Carl Zeiss of Thornwood, NY, as well as world general manager of Carl Zeiss Medical Group in Oberkochen, Germany. Before his stint at Carl Zeiss, Miller was group vice president, imaging systems, for Siemens Medical Systems in North America, and general manager for Siemens MRI division in Erlangen, Germany.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.